Acute exudative polymorphous vitelliform maculopathy during pembrolizumab treatment for metastatic melanoma: a case report

BACKGROUND: The use of immunomodulating therapy to treat various cancers has been on the rise and these immune checkpoint inhibitors are known to cause ocular side effects. In this article a case of acute exudative polymorphous vitelliform maculopathy (AEPVM) is reported which developed during a fir...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambert, Ine, Fasolino, Giuseppe, Awada, Gil, Kuijpers, Robert, ten Tusscher, Marcel, Neyns, Bart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180044/
https://www.ncbi.nlm.nih.gov/pubmed/34090381
http://dx.doi.org/10.1186/s12886-021-02011-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180044/
https://www.ncbi.nlm.nih.gov/pubmed/34090381
http://dx.doi.org/10.1186/s12886-021-02011-4

Ejemplares similares